News
4h
TipRanks on MSNPfizer’s Updated COVID-19 Vaccine Study: What Investors Need to KnowPfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled ‘Estimated Vaccine Effectiveness ...
4h
TipRanks on MSNPfizer’s New Study on Rimegepant: A Potential Game Changer for Migraine Treatment?Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has announced a new clinical study titled ‘CORRELATE-UK: ...
The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to negotiations that could either lead to a new alliance or Arvinas to seek a new ...
Drugmaker Viatris beat Wall Street estimates for second-quarter profit and revenue on Thursday, helped by demand for its products in China, sending its shares up nearly 5% in early trading.
Last December, the company raised its quarterly payout for the 16th consecutive year. The dividend yield investors could ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused 94% alignment with best ...
Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...
At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results